Entrepreneur: Pfizer and Moderna Could Earn $32 Billion from Sales of Covid-19 Vaccines
The creation, authorization and distribution of vaccines against COVID-19 represents a milestone for science and humanity. However, it will also be a millionaire source of income for pharmaceutical developers, such as Pfizer and Moderna , which could earn close to $ 32 billion from the expected drug.
“It is absolutely wrong for pharmaceutical companies like Pfizer and Moderna to benefit, and for their executives to make huge personal fortunes, from the COVID-19 vaccines that have been so heavily subsidized and supported by US taxpayers ,” said Eli Zupnick, spokesman. Accountable.US, a progressive patient advocacy and advocacy group.